BREAKING
KVH Industries Inc (KVHI) Reports Q4 Earnings 12 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 13 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 13 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 13 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 13 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 13 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 14 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 14 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 14 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 15 hours ago KVH Industries Inc (KVHI) Reports Q4 Earnings 12 hours ago Nio Inc (NIO) Beats Q4 EPS Estimates by a Wide Margin 13 hours ago Ultralife Corp (ULBI) Reports a net loss for Q4 FY25 13 hours ago Protara Therapeutics, Inc. (TARA) Reports Narrower Loss for Q4 13 hours ago Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 13 hours ago Esperion Therapeutics, Inc (ESPR) Misses Q4 EPS Estimates 13 hours ago Inspired Entertainment, Inc (INSE) Misses Q4 EPS Estimates 14 hours ago DNTH Stock Jumps 21.5% Despite Wider-Than-Expected Q4 Loss as Pipeline Prospects Fuel Rally 14 hours ago SuRo Capital Corp (SSSS) Reports Wider Loss Q4 EPS Estimates by 10.0% 14 hours ago Tenax Therapeutics Inc (TENX) Reports Q4 Earnings 15 hours ago
ADVERTISEMENT
Earnings

Verisk Analytics Q4 2026 Earnings Results

$VRSK February 18, 2026 2 min read
NYSE
$VRSK · Earnings

Verisk Analytics reported its fourth quarter and full year 2025 financial results, delivering steady revenue growth and stronger than expected earnings as demand for its insurance data and analytics services remained solid.

chirag-gupta · February 18, 2026

Verisk Analytics reported its fourth quarter and full year 2025 financial results, delivering steady revenue growth and stronger than expected earnings as demand for its insurance data and analytics services remained solid.

The company highlighted the strength of its subscription-based business model and pricing initiatives as key drivers of performance.

Revenue rises on subscription gains

For the quarter ended December 31, 2025, Verisk reported:

  • Revenue: $778.8 million, up from about $735.6 million a year earlier

Growth was driven by subscription increases, pricing actions, and contin company’s analytics solutions across the insurance industry.

Earnings beat expectations

Verisk posted better-than-expected profitability for the quarter:

  • EPS (GAAP): $1.82, beating analyst estimates

  • Earnings surpassed consensus forecasts by a notable margin ize a separate adjusted EPS figure in summary disclosures, focusing on overall earnings performance.

Management commentary: resilient business model

Management said the quarter demonstrated the resilience of Verisk’s recurring revenue model, supported by long term client relationships and mission-critical analytics products.

Leadership noted that ongoing investments in data, technology, and AI-driven solutions are helping insurers improve underwriting, pricing, and claims management, reinforcing Verisk’s role as a strategic partner to the industry.

The company also emphasized disciplined cost management, which contributed to margin stability despite a slower macro environment.

Outlook

Verisk expects continued steady growth supported by:

  • Recurring subscription revenue

  • Pricing improvements

  • Expansion of analytics and technology offerings

Management remains focused on driving profitable growth while investing in innovation and new capabilities.

Bottom line

Verisk’s Q4 2025 results highlight a company delivering consistent revenue growth and strong earnings, supported by a stable subscription model and disciplined execution. With ongoing investments in data analytics and AI capabilities, the company appears positioned for continued steady performance.

To view the company’s previous earnings and latest concall transcripts, click here  to visit the Alphastreet news channel.

ADVERTISEMENT